Contact Us Today|info@empharmd.com

I’ve Felt the Burn, and Live to Tell About It

After 6 years of experience since completion of my residency training, I have felt a tremendous amount of growth. As I have said earlier, the more experience I gain, the more I respect those who have it, and realize how little I truly have. There is no hidden meaning or cryptic message. Rather than resisting advice or guidance, I now listen to someone who's been through it all and come out wiser. It's such an [...]

By |2017-03-17T12:54:00-05:00March 17th, 2017|EM PharmD Blog|0 Comments

I've Felt the Burn, and Live to Tell About It

After 6 years of experience since completion of my residency training, I have felt a tremendous amount of growth. As I have said earlier, the more experience I gain, the more I respect those who have it, and realize how little I truly have. There is no hidden meaning or cryptic message. Rather than resisting advice or guidance, I now listen to someone who's been through it all and come out wiser. It's such an [...]

By |2017-03-17T12:54:00-05:00March 17th, 2017|EM PharmD Blog|0 Comments

Revisiting Esmolol for Refractory Ventricular Fibrillation in Cardiac Arrest

A 63-year-old male arrives to the resuscitation bay in cardiac arrest with ongoing cardiopulmonary resuscitation (CPR). Per EMS, the patient was found in ventricular fibrillation (Vfib) and has received defibrillation 6 times with four rounds of epinephrine and 2 doses of amiodarone (300 mg, 150 mg) prior to arrival. In the emergency department (ED), the patient is noted to still be in Vfib and a dose of 1 mg/kg of lidocaine is administered without termination [...]

By |2017-03-13T10:00:00-05:00March 13th, 2017|EM PharmD Blog|0 Comments

Antihistamines for Analgesia: Down to the Bone (Pain)

Clinicians in emergency departments across the country have increasingly become more savvy in their approach to the management of common pain conditions that patients may present with in this setting. In the effort to overcome the effects and consequences of the opioid abuse epidemic, great emphasis is now being placed in leveraging opioid-free alternatives in new ways for the management of these frequently encountered common pain conditions. This may involve utilizing target-specific agents in the [...]

By |2017-03-02T11:00:00-05:00March 2nd, 2017|EM PharmD Blog|0 Comments